Frequencies of CYP2C9 polymorphisms in a Syrian cohort
Abstract Background The cytochrome P450 family 2 subfamily C member 9 (CYP2C9) exhibits extensive genetic variability that may influence the metabolism of approximately 16–20% of all drugs. Understanding the frequency and functional impact of the CYP2C9 variants is crucial for the implementation of...
Saved in:
| Main Authors: | Weam Aldiban, Majd N. Aljamali, Lama A. Youssef |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Genomics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12864-025-11310-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics: Influence of CYP2C9*2 and *3 alleles polymorphisms on Iraqi type 2 diabetic patients
by: Ghada S. Rasool, et al.
Published: (2024-01-01) -
The Effect of Polymorphisms in the CYP2D6 and CYP2C9 Genes on the Clinical Efficacy of Tramadol and Ketorolac When Using the Accelerated Recovery Protocol in Patients With Uncomplicated Acute Calculous Cholecystitis Who Underwent Cholecystectomy
by: A. A. Muradyan, et al.
Published: (2020-10-01) -
Allele and genotype frequencies of variants in P450 cytochromes, transports, and DNA repair enzymes in the Dominican Republic population
by: Elizabeth Pérez-Duval, et al.
Published: (2025-03-01) -
Impact of <i>CYP2C9, CYP2C19</i> and <i>ABCB1</i> genetic polymorphisms on antiepileptic drug safety and efficacy
by: N. A. Galankin, et al.
Published: (2025-05-01) -
Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024-05-01)